ESSA Pharma Inc. (EPIX): Price and Financial Metrics
EPIX Price/Volume Stats
| Current price | $1.83 | 52-week high | $11.67 |
| Prev. close | $1.76 | 52-week low | $1.40 |
| Day low | $1.73 | Volume | 360,700 |
| Day high | $1.86 | Avg. volume | 297,466 |
| 50-day MA | $4.63 | Dividend yield | N/A |
| 200-day MA | $6.10 | Market Cap | 81.20M |
EPIX Stock Price Chart Interactive Chart >
ESSA Pharma Inc. (EPIX) Company Bio
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that is in Phase 1/2 clinical trial, which blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is based in Vancouver, Canada.
EPIX Price Returns
| 1-mo | -69.35% |
| 3-mo | -64.88% |
| 6-mo | N/A |
| 1-year | -68.12% |
| 3-year | -86.62% |
| 5-year | -65.79% |
| YTD | -72.27% |
| 2023 | 161.90% |
| 2022 | -82.25% |
| 2021 | 19.03% |
| 2020 | 116.91% |
| 2019 | 161.90% |
Loading social stream, please wait...